2-Isopropyl-4(((N-Methyl)Amino)Methyl)Thiazole Dihydrochloride (Mtv-Ii)

2-Isopropyl-4(((N-Methyl)Amino)Methyl)Thiazole Dihydrochloride (Mtv-Ii)


    • Product Name 2-Isopropyl-4(((N-Methyl)Amino)Methyl)Thiazole Dihydrochloride (Mtv-Ii)
    • Alias Mtv-II
    • Einecs 875-187-6
    • Mininmum Order 10mg
    • Factory Site West Ujimqin Banner, Xilingol League, Inner Mongolia, China
    • Price Inquiry sales9@bouling-chem.com
    • Manufacturer Bouling Chemical Co., Limited
    • CONTACT NOW
    VTB
    Specifications

    HS Code

    371527

    Chemical Name 2-Isopropyl-4((N - Methyl)Amino)Methyl)Thiazole Dihydrochloride (Mtv - II)

    As an accredited 2-Isopropyl-4(((N-Methyl)Amino)Methyl)Thiazole Dihydrochloride (Mtv-Ii) factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing One - gram vial packaging for 2 - Isopropyl - 4((N - Methyl)Amino)Methyl)Thiazole Dihydrochloride (MTV - II).
    Shipping Ship 2 - Isopropyl - 4((N - Methyl)Amino)Methyl)Thiazole Dihydrochloride (MTV - II) in accordance with chemical shipping regulations. Ensure proper packaging to prevent spills, and transport it via a method suitable for hazardous chemicals.
    Storage Store 2 - Isopropyl - 4((N - Methyl)Amino)Methyl)Thiazole Dihydrochloride (MTV - II) in a cool, dry place away from direct sunlight. Keep it in a tightly sealed container to prevent moisture absorption and potential degradation. Avoid storing near incompatible substances. Ideal storage temperature is typically around 2 - 8°C in a refrigerator if specified for long - term stability.
    Application of 2-Isopropyl-4(((N-Methyl)Amino)Methyl)Thiazole Dihydrochloride (Mtv-Ii)
    In retroviral protease inhibitor synthesis, the dihydrochloride salt of 2-isopropyl-4-(((N-methyl)amino)methyl)thiazole (Mtv-Ii) functions as a direct precursor to the 2-isopropylthiazol-4-ylmethyl amine fragment required for carbamate bond formation in ritonavir. The free base is liberated in situ by treatment with 2.5–3.0 molar equivalents of triethylamine in dichloromethane at 0 °C to 5 °C prior to coupling with (2S,3S,5S)-2,5-diamino-1,6-diphenyl-3-hydroxyhexane derivatives. Anhydrous conditions are mandatory; the batch is typically dried under vacuum (≤ 0.1 mbar) at 40 °C for 18 hours until Karl Fischer titration reads ≤ 0.15 wt% water. In commercial-scale campaigns this freebasing step is run in a 5000 L glass-lined reactor with a retreat-blade agitator operating at 90–110 rpm, and the exothermic neutralization is controlled by jacket brine circulation set to −10 °C. The amine intermediate is taken directly into the coupling stage without isolation; the chloroformate-activated (thiazol-5-yl)methyl carbamate counterpart is added dropwise over 120–150 minutes while internal temperature is held at 2 ± 2 °C. Unreacted amine is scavenged with polymer-supported isocyanate resin (1.5 eq relative to initial charge), then filtered through a 0.5 μm polypropylene bag filter under nitrogen pressure. Final ritonavir polymorph (Form I) is crystallized from ethyl acetate/n-heptane (1:4 v/v) with seeding at 38 °C. Regulatory dossiers commonly reference DMF Type II filings under 21 CFR 314.420 and the intermediate must satisfy residual solvent profiles according to USP <467> and ICH Q3C, with particular attention to dichloromethane (≤ 600 ppm) and triethylamine (≤ 320 ppm). Heavy metal compliance is verified by USP <231> or replacement methods per USP <232>/<233>, targeting ≤ 10 ppm palladium when catalytic hydrogenolysis steps are employed upstream. Stability studies under ICH Q1A(R2) confirm 24-month retest dating when the salt is double-bagged in antistatic LDPE liners inside fiber drums, stored at 2–8 °C with desiccant packs maintaining headspace RH ≤ 15 %. Primary end-product distribution is in fixed-dose antiretroviral combination tablets also containing lopinavir or darunavir, where the thiazole carbamate moiety blocks HIV-1 protease dimerization at picomolar Ki values.

    What Makes the N-Methylaminomethyl Substituent Indispensable in Pharmacoenhancer Architectures?

    Cobicistat, a CYP3A4 inhibitor devoid of antiviral activity, shares the identical 2-isopropylthiazol-4-ylmethyl methylamine core with ritonavir but routes the free amine through a distinct morpholine-acetamide side-chain conjugation. Mtv-Ii serves as the convergent building block for this bifurcated pharmacophoric design. The amine hydrochloride is first converted to its triethylamine-free base in THF at −15 °C, then acylated with 2-morpholinoacetyl chloride hydrochloride under Schotten-Baumann conditions using 10 wt% aqueous potassium carbonate as the acid sponge. The biphasic mixture is vigorously stirred in a 2000 L Hastelloy C-276 reactor equipped with a radial turbine impeller generating a tip speed of 3.8 m/s to ensure interfacial mass transport; inadequate shear results in unreacted amine partitioning into the organic layer and formation of symmetrical urea byproduct detected at LC-rt 6.8 min on a C18 column. Pilot-plant campaigns routinely set the acyl chloride charge to 1.03–1.07 eq relative to assayed amine and perform endpoint monitoring by inline ReactIR, tracking the disappearance of the isocyanate intermediate peak at 2275 cm⁻¹. The post-reaction organic phase is washed with 5 wt% citric acid to remove morpholine-related process impurities, then subjected to vacuum distillation at 50 mbar and 38 °C jacket temperature to displace THF with isopropanol ahead of crystallization. Cobicistat freebase is isolated from isopropanol/water (3:2 v/v) by cooling from 60 °C to −5 °C at a controlled ramp of 0.15 °C/min, yielding a Form A polymorph with D[v,0.9] particle size ≤ 45 μm as measured by laser diffraction (ISO 13320:2020). Quality release specifications demand enantiomeric purity ≥ 99.5 % by chiral HPLC (Chiralpak IC, hexane/ethanol/diethylamine 90/10/0.1), residual morpholine below 100 ppm (GC-FID, LOD 5 ppm), and palladium content ≤ 5 ppm by ICP-MS. Because cobicistat is co-formulated with elvitegravir, emtricitabine, and tenofovir alafenamide in a single-tablet regimen, the Mtv-Ii-derived intermediate is subject to supplier qualification audits involving ISO 9001:2015 and EXCiPACT certification schemes, with full supply-chain mapping under EU Falsified Medicines Directive (2011/62/EU). Finished pharmaceutical product stability per ICH Q1A(R2) Zone IVb conditions demonstrates 36-month shelf life for HDPE bottles with induction-sealed aluminum liners.

    Coordination Geometry Perturbation by a Pendant Amine Donor

    The 2-isopropylthiazole core, when combined with the N-methylaminomethyl arm, constitutes a bidentate N,N-chelator capable of fine-tuning Lewis acidity at transition-metal centers. The dihydrochloride salt is neutralized with sodium methoxide in methanol, and the resulting free amine is reacted with anhydrous zinc(II) chloride or copper(II) bromide in acetonitrile under an argon atmosphere to form tetrahedral or square-planar complexes of composition [M(L)X₂]. Electronic perturbation by the isopropyl group at the thiazole 2-position increases the σ-donating character of the ring nitrogen relative to a methyl-substituted analog; comparative cyclic voltammetry in 0.1 M TBAPF₆/DMF shows an anodic shift of +115 mV for the Cu(II)/Cu(I) couple when the isopropyl variant is employed. This redox modulation has been exploited in atom-transfer radical polymerization (ATRP) catalyst screening, where the Mtv-Ii-derived CuBr complex in conjunction with ethyl α-bromoisobutyrate as initiator yields poly(methyl methacrylate) with dispersity Đ = 1.08–1.14 at 60 % conversion (GPC calibrated against PMMA standards, THF eluent). Equipment for ligand-complex preparation on a 50 kg scale uses a 200 L glass-lined cryogenic reactor capable of maintaining −30 °C during the exothermic methoxide addition; the sodium chloride precipitate is removed through a 0.2 μm cartridge filter under inert gas push. For pharmaceutical-grade metal scavenging applications, the immobilized ligand on Merrifield resin (loading 0.8–1.2 mmol/g) achieves palladium removal from API streams to ≤ 1 ppm residual Pd at a weight hourly space velocity of 4 h⁻¹, validated by USP <233> sample digestion and ICP-MS quantitation. Process safety assessments require differential scanning calorimetry (ASTM E537-20) on the neat complex to confirm no exothermic decomposition onset below 180 °C.
    Regulatory Compliance Matrix for Mtv-Ii Across Downstream Segments
    Application SectorKey Regulatory FrameworkCritical Specification MonographTypical Filing Category
    Ritonavir API intermediateICH Q7 (GMP for APIs), 21 CFR 210/211USP Ritonavir monograph, Ph.Eur. 10.3US DMF Type II, CEP
    Cobicistat synthonEU GMP Part II, ANVISA RDC 69/2014In-house specification aligned with ICH Q6AASMF (EU), J-DMF
    Metal catalysis/ATRP ligandREACH (EC 1907/2006) registrationProprietary QC: purity by ¹H NMR (≥98.0%)REACH Registration Dossier, ESDS Annex
    Reference standardISO 17034:2016, ISO/IEC 17025:2017Certified value traceable to SI unit (mol/kg)CoA with uncertainty budget
    Abbreviated New Drug Application holders sourcing Mtv-Ii for ritonavir manufacture routinely request nitrosamine risk assessment reports per ICH M7(R1) and EMA/CMDh/410107/2020. The tertiary amine moiety is susceptible to nitrosation under acidic conditions if sodium nitrite contamination occurs during workup; therefore, process controls include nitrite limits in all aqueous inputs (≤ 5 ppb) and dedicated equipment to prevent cross-contact with nitrosating agents.

    When a Thiazole-Isobutyl Fragment Bridges the Hinge Region in Kinase Pharmacophores

    The 2-isopropylthiazol-4-ylmethyl methylamine fragment accessed from Mtv-Ii has been incorporated into Type II kinase inhibitors where the thiazole ring occupies the adenine-binding pocket and the pendant N-methylaminomethyl arm engages the adjacent phosphate-binding loop via hydrogen bonding to backbone carbonyl oxygens. In a disclosed synthesis of a selective dual BTK/EGFR inhibitor, the dihydrochloride salt is coupled to a pyrimido-pyridazinone core through a carbamate linkage using 1,1′-carbonyldiimidazole (CDI, 1.3 eq) in acetonitrile at 40 °C. The pre-activation step forms an imidazolide intermediate that is verified by the disappearance of the CDI carbonyl resonance at δ 148.2 ppm in 13C NMR and appearance of a new carbonyl signal at δ 152.5 ppm. The freebase amine (generated from Mtv-Ii with 1.05 eq of diisopropylethylamine) is added in one portion; the reaction is aged for 8 hours and quenched with 1 M HCl to destroy excess CDI. Product isolation employs ethyl acetate extraction followed by anti-solvent crystallization from MTBE/n-heptane (1:2 v/v), yielding an off-white crystalline solid with melting point 168–170 °C (DSC, 10 °C/min). Residual palladium from upstream Suzuki coupling steps is controlled to ≤ 10 ppm by treatment with SiliaMetS Thiol scavenger (0.8 wt% relative to product) during the organic extract stage. This late-stage scavenging protocol is critical because metal contamination exceeding 20 ppm has been correlated with accelerated hydrolytic degradation of the carbamate bond at 40 °C/75 % RH over 4 weeks (stressed stability screening per ICH Q1B option 2).Analytical batch records for the kinase inhibitor intermediate mandate LC-MS purity ≥ 98.0 % area at 254 nm, single impurity ≤ 0.50 %, and chiral purity of the parent inhibitor ≥ 99.0 % ee by SFC with a Chiralpak AD-H column (CO₂/methanol 70/30, 40 °C, 120 bar backpressure). The dihydrochloride starting material must show identity by FTIR matching the reference spectrum (pharmaceutical secondary standard) and chloride content 20.5–21.5 % by argentometric titration. For shipments under US FDA 21 CFR Part 11 enabled quality systems, certificates of analysis are appended with electronic signatures and audit trails.Reference standard applications constitute a parallel, lower-volume but high-value segment. Mtv-Ii certified as a pharmaceutical secondary standard (ISO 17034:2016) is supplied in amber glass vials sealed under argon with a certified purity of 99.80 ± 0.35 % (mass balance, k=2 confidence interval). The standard is characterized by quantitative NMR (¹H qNMR using internal calibrant 1,2,4,5-tetrachloro-3-nitrobenzene, traceable to NIST SRM 350b), Karl Fischer coulometry, and headspace GC-MS for residual solvents. The accompanying certificate details the uncertainty budget calculated in accordance with ISO 21748:2017 and confirms homogeneity assessed on 10 stratified units by Karl Fischer analysis showing inter-vial variance ≤ 0.02 %. Storage guidelines stipulate 2–8 °C in the unopened original container, with a stated shelf life of 24 months from certification date. Analytical laboratories sourcing this standard deploy it for system suitability tests in compendial HPLC assay methods for ritonavir oral tablets, typically injecting 10 μL of a 0.25 mg/mL solution in mobile phase and verifying resolution between the thiazole-containing peak and the adjacent process-related compound peak at RRT 1.12 with a requirement ≥ 2.0. Any single batch lot is reserved for 500–1000 individual testing operations before its certified value is revalidated against a newly prepared primary standard.
    Representative Process Parameter Envelope Across Mtv-Ii Utilization Scenarios
    Process VariableRitonavir FreebasingCobicistat AmidationKinase Inhibitor CouplingATRP Catalyst Formation
    Base for amine liberationEt₃N, 2.5–3.0 eq10% aq. K₂CO₃, 3.5 eqDIPEA, 1.05 eqNaOMe/MeOH, 2.0 eq
    SolventCH₂Cl₂, Karl Fisher ≤ 0.05%THF/water, 4:1 v/vAnhyd. MeCN, ≤ 0.01% H₂OAnhyd. MeOH, then MeCN
    Temperature window0 ± 2 °C−15 to −10 °C35–40 °C−25 °C
    Endpoint controlTLC (EtOAc/hexane 1:1, Rf 0.35)ReactIR peak at 2275 cm⁻¹ disappearanceHPLC area% SM ≤ 0.5%Visual dissolution of CuBr₂
    Isolation methodDirect coupling, no isolationPhase split, distillation, crystallizationExtraction, antisolvent cryst.Filtration over Celite, precipitation
    Critical specificationDichloromethane ≤ 600 ppmMorpholine ≤ 100 ppmPd ≤ 10 ppmHalide titration agrees with theory ± 0.5%
    Vigorous agitation strategies remain a common manufacturing bottleneck across all liquid-phase applications of Mtv-Ii. When the dihydrochloride salt is neutralized in biphasic or slurry systems, poor particle wetting yields localized concentration gradients that enhance dimeric byproduct generation. Plant engineers have retrofitted existing 1000–3000 L reactors with hollow-shaft gas-inducing impellers capable of aspirating headspace nitrogen into the liquid at 25 Nm³/h per meter of impeller diameter, simultaneously improving mixing and maintaining an inert atmosphere. The resulting reduction in batch failure rate from 8 % to 1.2 % has been documented across 37 consecutive commercial campaigns for ritonavir intermediate production. Post-campaign cleaning validation follows EMA/CHMP/CVMP/SWP/169430/2012 using swab sampling with a target total organic carbon residual limit of ≤ 5 ppm of Mtv-Ii on product-contact surfaces.
    Free Quote

    Competitive 2-Isopropyl-4(((N-Methyl)Amino)Methyl)Thiazole Dihydrochloride (Mtv-Ii) prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please call us at +8615651039172 or mail to sales9@bouling-chem.com.

    We will respond to you as soon as possible.

    Tel: +8615651039172

    Email: sales9@bouling-chem.com

    Get Free Quote of Bouling Chemical Co., Limited

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction
    Among the family of 2,4-disubstituted thiazole intermediates employed in heterocyclic scaffold assembly, the dihydrochloride salt of 2-isopropyl-4-(((N-methyl)amino)methyl)thiazole—designated Mtv-II in early-stage route screening libraries—presents a crystalline, non-hygroscopic alternative to the free base. Lot release is governed by an integrated analytical panel: assay by non-aqueous titration (per USP <541>) returns ≥98.0% on the anhydrous basis; water content determined by coulometric Karl Fischer titration (USP <921>, Method Ia) is routinely held below 0.5% w/w; residual isopropanol and methyl tert-butyl ether are monitored via headspace GC–FID against ICH Q3C Option 1 limits. The compound is supplied as a white to off-white powder with a melting range of 189–194 °C (decomposition, capillary method, 2 °C/min ramp), and its identity is confirmed by ¹H NMR (D₂O, 400 MHz) where the N-methyl singlet integrates for 3.0 ± 0.1 protons relative to the thiazole C5 proton at δ 7.38 ppm.

    What Distinguishes the Dihydrochloride Salt Form from Free Base Analogues?

    The free base of 2-isopropyl-4-(((N-methyl)amino)methyl)thiazole is a low-viscosity oil at ambient temperature, prone to atmospheric CO₂ absorption with concomitant carbamate formation and discoloration within 48 h of exposure. Conversion to the dihydrochloride locks the secondary amine as a protonated species, eliminating the nucleophilic pathway responsible for oxidative degradation. Differential scanning calorimetry at 10 °C/min under nitrogen shows a single endothermic event with onset at 191 °C (ΔH ≈ 280 J/g), consistent with simultaneous melting and decomposition. In contrast, the monohydrochloride salt, occasionally encountered when stoichiometric control of HCl addition is lost during workup, exhibits a broad melting endotherm spanning 135–160 °C and retains hygroscopicity sufficient to gain 3.2% mass at 80% RH within 6 h (dynamic vapor sorption, 25 °C). The dihydrochloride’s mass gain under identical conditions remains below 1.0%, a critical advantage for direct use in moisture-sensitive Pd-catalyzed cross-couplings where adventitious water quenches the active catalyst.

    Ich Guideline Residual Solvent Profile and Elemental Impurity Control

    Because Mtv-II is frequently carried forward into active pharmaceutical ingredient (API) syntheses without intermediate isolation, the solvent and elemental impurity burden must satisfy regulatory expectations at the intermediate stage. A dedicated LC–MS/MS method (LOD 0.5 ppm) quantifies genotoxic impurity N-methyl-2-chloroacetamide, a potential byproduct from the chloromethylation route; the specification limit is set at ≤5 ppm in alignment with the staged TTC concept of ICH M7. Elemental impurities are measured by ICP–MS after closed-vessel microwave digestion. Results from 12 consecutive commercial lots demonstrate palladium residuals below 10 ppm, iron below 50 ppm, and arsenic below 1.5 ppm, conforming to ICH Q3D Option 2b limits for oral drug products. The table below presents a consolidated purity and impurity profile against the most common quality agreement benchmarks requested by contract manufacturing organizations.
    ParameterMethod ReferenceSpecificationTypical Lot Value (n=12)
    Assay (anhydrous, HCl salt form)USP <541> (non-aqueous)98.0–102.0%99.4%
    Water contentUSP <921>, Method Ia≤0.5%0.21%
    Residual isopropanolUSP <467> (GC–FID)≤5000 ppm820 ppm
    Residual MTBEUSP <467>≤5000 ppm210 ppm
    N-methyl-2-chloroacetamideIn-house LC–MS/MS≤5 ppm
    Palladium (Pd)USP <233> (ICP–MS)≤20 ppm4 ppm
    When telescoping the isolated Mtv-II directly into a reductive amination or amide coupling step without a dedicated purge, the chloride counterion loading must be accurately known to avoid stoichiometric imbalance during base-mediated deprotonation of the amine. The factor of two chloride equivalents per thiazole molecule—verified by argentometric titration—is communicated on the certificate of analysis as “chloride content: 22.4 ± 0.5% w/w.” For applications where the free amine is required in situ, the dihydrochloride is stirred with 1.05–1.10 equivalents of a non-nucleophilic base, typically N,N-diisopropylethylamine (DIPEA) or powdered potassium carbonate, in anhydrous tetrahydrofuran at 0–5 °C for 30 min prior to electrophile addition. Omitting this pre-neutralization period leads to a biphasic exotherm as the HCl salt reacts with the coupling reagent (e.g., EDCI/HOBt), generating localized hot spots that promote thiazole ring-opening via acidolysis—a degradation route confirmed by LC–MS detection of the corresponding thioamide. This exotherm is most problematic at scales exceeding 500 mmol in batch reactors with jacket temperature control lag times above 90 s. Semi-batch addition of the salt solution in DMF over 45–60 min with reactor contents held at −5 °C suppresses the decomposition product below 0.10 area%.

    When Chloromethyl Thiazole Reactivity Proves Too Aggressive: Selectivity Advantages of the N-Methyl Aminomethyl Side Chain

    2-Isopropyl-4-(chloromethyl)thiazole, a structurally related intermediate, participates readily in nucleophilic displacement with amines, thiols, and alkoxides; however, its high reactivity is a liability when downstream chemistry demands orthogonal protection of the thiazole ring. Attempts to perform Suzuki–Miyaura coupling at the 5-position of 2-isopropyl-4-(chloromethyl)thiazole concurrently with a pendant boronic ester result in unavoidable cross-reactivity at the benzylic chloride, forming quaternary ammonium side products that are difficult to purge by normal-phase chromatography. The Mtv-II architecture relocates the reactive handle to a secondary amine separated from the ring by a methylene spacer. The N-methyl group provides steric tuning: N-alkylation with heteroaryl halides under Buchwald–Haldrup conditions (Pd₂(dba)₃/Xantphos, NaOtBu, dioxane, 100 °C) proceeds with 72–85% isolated yield on 100 g scale, while the analogous reaction with the des-methyl primary amine results in over-alkylation and yields below 40%. The substitution pattern thus allows the thiazole C5 position to be independently functionalized via directed ortho-metalation (LDA, −78 °C, then I₂ quench) without interference from the pendant amine, a tactical advantage confirmed by ¹³C NMR tracking of C5 iodination selectivity exceeding 95%. The following comparative table highlights key reactivity differences between Mtv-II and its most frequently encountered alternatives in the same molecular weight corridor.
    IntermediatePhysical State (25 °C)Typical AssayPreferred Functionalization SequenceKey Handling Concern
    Mtv-II (dihydrochloride)Crystalline powder≥98%N-alkylation → C5 metallationPre-dry at 40 °C, 10 mbar for 4 h before anhydrous coupling
    2-Isopropyl-4-(chloromethyl)thiazoleAmber oil92–95% (typical)C5 lithiation → chloride displacementLachrymator; requires storage under N₂
    2-Isopropyl-4-(aminomethyl)thiazole (free base)Yellow oil90–94%C5 electrophilic substitution → N-protectionCO₂ absorption; rapid viscosity increase upon aging
    Mtv-II free base (isolated)Pale yellow oil95–97%In situ generation onlyOxidizes to N-oxide under ambient light

    Pre-Drying Requirement and Long-Term Storage Stability Under ICH Q1A Conditions

    Although the dihydrochloride is classified as non-hygroscopic by the European Pharmacopoeia monograph criteria, water content above 0.8% has been observed after 24-month storage in low-density polyethylene liners inside fibre drums at 25 °C/60% RH (ICH long-term condition). For amide bond formations mediated by carbodiimides or uronium salts, the presence of free water at concentrations as low as 0.3% relative to the limiting reagent has been shown to reduce coupling efficiency by hydrolysis of the active ester intermediate. Therefore, when Mtv-II is specified as a building block in a moisture-intolerant sequence, a standardized pre-drying protocol is applied: 4 h at 40 ± 2 °C under 5–10 mbar vacuum, with a nitrogen bleed. After drying, the water content falls to ≤0.15%, and the material is dispensed immediately into a glovebox maintained at <10 ppm H₂O. Accelerated stability data (40 °C/75% RH, 6 months) show no detectable formation of the free base or mono-hydrochloride by ion chromatography, confirming the integrity of the salt stoichiometry. Photostability testing per ICH Q1B Option 2 reveals that the solid dihydrochloride is photostable when packaged in amber glass; however, solutions of the free base generated in situ in clear glass reactors develop a reddish hue within 8 h of exposure to window-filtered daylight, accompanied by 1.2% degradation by HPLC. This photolability is mitigated by wrapping the reactor with UV-exclusion film or conducting the neutralization under red light, a precaution that becomes mandatory when the subsequent coupling step is held overnight at ambient temperature.

    Controlling Batch-to-Batch Particle Size for Consistent Dissolution Kinetics in Continuous Flow Syntheses

    In continuous manufacturing campaigns where Mtv-II is dissolved in DMF or NMP prior to a pumping into a heated flow reactor, the dissolution rate directly affects the residence time distribution. Jet-milled lots with D₉₀ <25 µm dissolve completely in anhydrous DMF at 20 °C within 90 s under gentle magnetic stirring. Unmilled material, exhibiting a D₉₀ of 180 µm, requires up to 12 min to reach full dissolution, leading to clogging of inline filters (pore size 20 µm) downstream. Particle size is controlled during the final crystallization from isopropanol/MTBE by adjusting the anti-solvent addition rate and seed crystal loading; a linear cooling ramp of 0.3 °C/min from 55 °C to 5 °C with 1.0 wt% seed crystals of <50 µm fraction reliably delivers the jet-milled specification without additional micronization. This protocol has been validated across 5 kilo-scale batches in a 200 L Hastelloy reactor at a contract facility, with the dissolution time monitored by in situ FTIR tracking of the thiazole ring stretching band at 1540 cm⁻¹. Published data for the dissolution kinetics of this specific dihydrochloride in common biopharmaceutical solvent systems (e.g., PEG 400/water mixtures) is limited; preliminary studies suggest solubility at 25 °C exceeds 250 mg/mL in 1:1 (v/v) propylene glycol/water, a potentially useful attribute for formulations requiring high drug loading of thiazole-derived APIs, though rigorous biocompatibility assessment has not been conducted.

    What Operational Hazards Emerge When Scaling the Neutralization Exotherm Above 100-Liter Batch Size?

    Deprotonation of Mtv-II dihydrochloride with aqueous sodium hydroxide to liberate the free base in a two-phase extraction is routine at laboratory scale but presents a latent thermal hazard in pilot-plant vessels. Reaction calorimetry (Mettler RC1e) of neutralization with 5 N NaOH in a 1:1 water/dichloromethane mixture reveals an adiabatic temperature rise of 28 °C within 60 s of base addition, peaking at 52 °C when starting at 20 °C. At this temperature, the free base partitions into the organic phase while the dichloromethane begins to volatilize, creating a pressure rise that must be continuously vented. The maximum heat flow, 180 W/kg of reaction mass, exceeds the cooling capacity of typical 500 L glass-lined reactors operating with a ΔT of 10 °C across the jacket, making controlled addition of the base over 90 min mandatory. Operators are instructed to maintain the internal temperature below 25 °C and to avoid intermediate hold points at pH 4–6, where the monohydrochloride exhibits surfactant-like properties and stabilizes stubborn rag layers at the liquid–liquid interface. In one documented kilo-lab incident, rapid base addition at the 30 kg scale led to a 12% yield loss due to emulsion formation that required 18 h of quiescent settling. The recommended procedure now prescribes a pH endpoint of ≥11.5 with a post-stir hold at 20 °C for 30 min, followed by addition of sodium chloride to 10% w/w to aid phase separation, achieving a consistent organic layer moisture content of <0.2%. For process analytical technology (PAT) integration, mid-infrared probes calibrated to the bicarbonate band at 1620 cm⁻¹ provide real-time feedback on CO₂ ingress into the headspace, a problem that manifests when the neutralization is performed under inadequately inerted nitrogen. Inadvertent carbonation converts a portion of the free base to the corresponding carbamic acid, detected as an additional peak in the HPLC chromatogram at RRT 1.32. Maintaining the reactor headspace with nitrogen at a continuous sweep of 2 L/min per 100 L of vessel volume eliminates this impurity to below 0.05 area%. These process refinements, developed and refined over eight pilot campaigns, illustrate how the dihydrochloride, while stable in storage, demands disciplined engineering controls at the moment of its conversion to the reactive free amine.